| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1630 |
| Trial ID | NCT02851589 |
| Disease | Acute Lymphoblastic Leukemia | Follicular Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-Cell Lymphoma | B-Cell Prolymphocytic Leukemia | Mantle Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PCAR-019 |
| Co-treatment | decitabine |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma |
| Year | 2016 |
| Country | China |
| Company sponsor | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
| Other ID(s) | PG-019-002 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||